Scholars@Duke publication: Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF

Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF

Publication , Conference

Chapman, B; Hellkamp, A; Thomas, L; Albert, N; Butler, J; Patterson, JH; Hernandez, A; Williams, F; Shen, X; Spertus, J; Fonarow, G; Devore, A

Published in: JOURNAL OF CARDIAC FAILURE

2022

JOURNAL OF CARDIAC FAILURE

1532-8414

1071-9164

2022

S33 / S33

APA

Chicago

ICMJE

MLA

NLM

Chapman, B., Hellkamp, A., Thomas, L., Albert, N., Butler, J., Patterson, J. H., … Devore, A. (2022). Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF. In JOURNAL OF CARDIAC FAILURE (Vol. 28, pp. S33–S33).

Chapman, Brittany, Anne Hellkamp, Laine Thomas, Nancy Albert, Javed Butler, J Herbert Patterson, Adrian Hernandez, et al. “Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF.” In JOURNAL OF CARDIAC FAILURE, 28:S33–S33, 2022.

Chapman B, Hellkamp A, Thomas L, Albert N, Butler J, Patterson JH, Hernandez A, Williams F, Shen X, Spertus J, Fonarow G, Devore A. Use Of Sacubitril-valsartan And Associated Outcomes By Race And Ethnicity In Patients With Heart Failure With Reduced Ejection Fraction: Data From Champ-HF. JOURNAL OF CARDIAC FAILURE. 2022. p. S33–S33.

JOURNAL OF CARDIAC FAILURE

1532-8414

1071-9164

2022

S33 / S33